相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's disease drug development and the problem of the blood-brain barrier
William A. Pardridge
ALZHEIMERS & DEMENTIA (2009)
Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood-Brain Barrier Delivery in the Mouse
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Comparison of Blood-Brain Barrier Transport of Glial-Derived Neurotrophic Factor (GDNF) and an IgG-GDNF Fusion Protein in the Rhesus Monkey
Ruben J. Boado et al.
DRUG METABOLISM AND DISPOSITION (2009)
AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Tumor Necrosis Factor Receptor-IgG Fusion Protein for Targeted Drug Delivery across the Human Blood-Brain Barrier
Eric Ka-Wai Hui et al.
MOLECULAR PHARMACEUTICS (2009)
Pharmacokinetics and Safety in Rhesus Monkeys of a Monoclonal Antibody-GDNF Fusion Protein for Targeted Blood-Brain Barrier Delivery
William M. Pardridge et al.
PHARMACEUTICAL RESEARCH (2009)
Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer
Fancy C. Thomas et al.
PHARMACEUTICAL RESEARCH (2009)
Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2008)
Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses
William M. Pardridge
BIOCONJUGATE CHEMISTRY (2008)
GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When Administered Immediately after Lateral Fluid Percussion Brain Injury and Its Pharmacodynamic Effects on IL-1β and MIP-2 in Rats
Thomas Lieutaud et al.
JOURNAL OF NEUROTRAUMA (2008)
IgG-Paraoxonase-1 Fusion Protein for Targeted Drug Delivery across the Human Blood-Brain Barrier
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2008)
Targeting of the CNS in MPS-IH using a nonviral transferrin-α-L-iduronidase fusion gene product
Mark J. Osborn et al.
MOLECULAR THERAPY (2008)
LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model
Babak Nazer et al.
NEUROBIOLOGY OF DISEASE (2008)
Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Targeted delivery of proteins across the blood-brain barrier
Brian J. Spencer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and Aβ fibril disaggregation
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2007)
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides
Emi Shoji-Hosaka et al.
JOURNAL OF BIOCHEMISTRY (2006)
Point source concentration of GDNF may explain failure of phase II clinical trial
Michael F. Salvatore et al.
EXPERIMENTAL NEUROLOGY (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov et al.
JOURNAL OF LIPID RESEARCH (2005)
Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease
A Eslamboli et al.
JOURNAL OF NEUROSCIENCE (2005)
Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption
DY He et al.
JOURNAL OF NEUROSCIENCE (2005)
Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and α-L-iduronidase or acid α-glucosidase
WS Prince et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier
WH Pan et al.
JOURNAL OF CELL SCIENCE (2004)
Early blood-brain barrier disruption in human focal brain ischemia
LL Latour et al.
ANNALS OF NEUROLOGY (2004)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system
J Husemann et al.
GLIA (2002)
Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector
BW Song et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Imaging brain amyloid of Alzheimer disease in vivo in Transgenic mice with an Aβ peptide radiopharmaceutical
HJ Lee et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Fiblast (trafermin) in acute stroke: Results of the European-Australian phase II/III safety and efficacy trial
J Bogousslavsky et al.
CEREBROVASCULAR DISEASES (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system
Y Zhang et al.
STROKE (2001)
Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of tbe neurotrophin
Y Zhang et al.
BRAIN RESEARCH (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
α-L-iduronidase forms semi-crystalline spherulites with amyloid-like properties
L Ruth et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2000)
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor
MJ Coloma et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
